Filament Health Corp. (FLHLF)

USD 0.02

(54.55%)

Market Cap (In USD)

4.45 Million

Revenue (In USD)

2.13 Million

Net Income (In USD)

-5.32 Million

Avg. Volume

26.43 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0212-0.12
PE
-1.7
EPS
-0.01
Beta Value
1.0
ISIN
CA31685W1068
CUSIP
-
CIK
-
Shares
261793979.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Benjamin Lightburn
Employee Count
-
Website
https://filament.health
Ipo Date
2021-09-03
Details
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.